Cost-effectiveness of axicabtagene ciloleucel as secondline therapy for patients large B-cell lymphoma (LBCL) in the United States Meeting Abstract


Authors: Perales, M. A.; Kuruvilla, J.; Snider, J. T.; Vadgama, S.; Blissett, R.; El-Moustaid, F.; Smith, N.; Patel, A.; Johnston, P. B.
Abstract Title: Cost-effectiveness of axicabtagene ciloleucel as secondline therapy for patients large B-cell lymphoma (LBCL) in the United States
Meeting Title: 2022 Tandem Meetings of ASTCT and CIBMTR
Journal Title: Transplantation and Cellular Therapy
Volume: 28
Issue: 3 Suppl.
Meeting Dates: 2022 Apr 23-26
Meeting Location: Salt Lake City, UT
ISSN: 2666-6375
Publisher: Elsevier Inc.  
Date Published: 2022-03-01
Start Page: S475
Language: English
PROVIDER: manual
DOI: 10.1016/S2666-6367(22)00782-5
Notes: Meeting Abstract: LBA2 -- Located within the section named "Late Breaking Abstracts"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Miguel-Angel Perales
    914 Perales